A clinical study for patients with refractory or relapsed DLBCL is now enrolling.
07 Jan 2022, 14:33
A clinical study for patients with refractory or relapsed DLBCL is now enrolling.
Let’s take the next step in your fight against DLBCL!
#lymphoma, #nonhodgkin, #cancer, #cancertreatment, #clinicalstudy